Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis
Serrated colorectal cancer (CRC) accounts for approximately 25% of cases and includes tumours that are among the most treatment resistant and with worst outcomes. This CRC subtype is associated with activating mutations in the mitogen-activated kinase pathway gene, BRAF, and epigenetic modifications...
Main Authors: | Lannagan, T, Lee, Y, Wang, T, Roper, J, Bettington, M, Fennell, L, Vrbanac, L, Jonavicius, L, Somashekar, R, Gieniec, K, Yang, M, Ng, J, Suzuki, N, Ichinose, M, Wright, J, Kobayashi, H, Putoczki, T, Hayakawa, Y, Leedham, S, Abud, H, Yilmaz, Ö, Marker, J, Klebe, S, Wirapati, P, Mukherjee, S, Tejpar, S, Leggett, B, Whitehall, V, Worthley, D, Woods, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2018
|
Similar Items
-
Oncogenic BRAF mutation induces DNA methylation changes in a murine model for human serrated colorectal neoplasia
by: Catherine E. Bond, et al.
Published: (2018-01-01) -
Left-sided sessile serrated polyps/adenomas.
by: Chetty, R, et al.
Published: (2013) -
The CIMP Phenotype in BRAF Mutant Serrated Polyps from a Prospective Colonoscopy Patient Cohort
by: Winnie C. Fernando, et al.
Published: (2014-01-01) -
Diagnosis of sessile serrated polyps/adenomas: What does this mean for the pathologist, gastroenterologist and patient
by: Leedham, S, et al.
Published: (2013) -
Diagnosis of sessile serrated polyps/adenomas: what does this mean for the pathologist, gastroenterologist and patient?
by: Leedham, S, et al.
Published: (2013)